CanSino Biologics Inc. (HKG:6185)
Hong Kong
· Delayed Price · Currency is HKD 34.60
+0.30 (0.87%)
Jun 6, 2025, 4:08 PM HKT
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of 12.02 billion as of June 6, 2025. Its market cap has increased by 31.25% in one year.
Market Cap
12.02B
Enterprise Value
10.15B
Revenue
931.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
34.60
Market Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 7.57B to 12.02B, an increase of 58.78%. That is a compound annual growth rate of 7.75%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 240.35B |
| Hansoh Pharmaceutical Group Company | 157.27B |
| JD Health International | 126.08B |
| Innovent Biologics | 119.26B |
| WuXi Biologics | 101.31B |
| CSPC Pharmaceutical Group | 89.83B |
| Sino Biopharmaceutical | 81.02B |
| Sichuan Kelun-Biotech Biopharmaceutical | 75.74B |